Our core capabilities
Small Molecules
- Custom synthesis & route scouting
- Process development & optimization
- Scale‑up from grams to commercial volumes
- Commercial API manufacturing under cGMP
Peptides
- SPPS, LPPS & hybrid synthesis approaches
- Large‑scale fragment manufacturing
- Complex, long‑chain & high‑potency peptides
- Commercial peptide manufacturing for regulated markets
We are known for solving chemistry problems others avoid — and executing them at scale.
What Sets Neuland Apart
Complex Chemistry DNA
Not just scale — we are recognized for chemical problem solving, process maturity, and robustness.
Proven Commercial Execution
Experience supporting late phase and commercial products, not just early R&D.
Hybrid Capability Advantage
Seamlessly combining solid phase and liquid phase synthesis to optimize yield, timelines, and cost.
Regulatory Confidence
Strong inspection history and documentation rigor for US FDA and global markets.
What Happens Next
Your first discussion with Neuland
- Confidential overview of your molecule or program
- Fit assessment with our scientific & manufacturing teams
- Clear next steps — feasibility, timelines, and engagement model
Case Studies: Solving complex development & scale‑Up challenges
Phase III to Commercial CNS API
Converting a High‑Risk CNS API into a Scalable Asset
Read case study
